
Accelerate Diagnostics AXDX
Accelerate Diagnostics Historical Prices | AXDX
Annual Historical Prices Accelerate Diagnostics
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.49 | 5.22 | 7.58 | 16.9 | 11.5 | 26.2 | 20.8 | 21.5 | 19.2 | 12.2 | 4.03 | 1.21 |
Annual performance
Select metrics to display
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 26.2 | 0.49 | 12.2 |
Historical Prices of other stocks in the Diagnostics research industry
| Issuer | Historical Prices | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Psychemedics Corporation
PMD
|
2.93 | - | -1.84 % | $ 15.3 M | ||
|
IDEXX Laboratories
IDXX
|
636 | $ 675.24 | -2.09 % | $ 54.3 B | ||
|
Motus GI Holdings
MOTS
|
0.64 | - | -34.28 % | $ 263 K | ||
|
Biodesix
BDSX
|
14.9 | $ 7.55 | -9.1 % | $ 57 M | ||
|
HTG Molecular Diagnostics
HTGM
|
3.36 | - | -20.0 % | $ 1.06 M | ||
|
Agilent Technologies
A
|
111 | $ 169.82 | -3.21 % | $ 48.2 B | ||
|
Charles River Laboratories International
CRL
|
155 | $ 314.38 | -4.13 % | $ 15.6 B | ||
|
Quest Diagnostics Incorporated
DGX
|
210 | $ 257.78 | -0.4 % | $ 28.6 B | ||
|
Danaher Corporation
DHR
|
210 | $ 220.3 | -3.19 % | $ 157 B | ||
|
DexCom
DXCM
|
65.4 | $ 79.02 | -1.46 % | $ 30.8 B | ||
|
Anixa Biosciences
ANIX
|
3.19 | $ 2.44 | -6.15 % | $ 79.2 K | ||
|
Celcuity
CELC
|
115 | $ 53.32 | -5.31 % | $ 2.49 B | ||
|
Guardant Health
GH
|
107 | $ 145.9 | 0.21 % | $ 18.3 B | ||
|
BioNano Genomics
BNGO
|
1.46 | $ 0.82 | -7.56 % | $ 4.46 M | ||
|
Bioventus
BVS
|
9.12 | $ 9.89 | -0.65 % | $ 659 M | ||
|
IQVIA Holdings
IQV
|
165 | $ 245.67 | -1.92 % | $ 42.2 B | ||
|
Laboratory Corporation of America Holdings
LH
|
287 | $ 367.68 | -0.44 % | $ 30.6 B | ||
|
Castle Biosciences
CSTL
|
16.3 | $ 32.69 | -2.14 % | $ 948 M | ||
|
Mettler-Toledo International
MTD
|
1.38 K | $ 1 667.59 | -2.3 % | $ 34.4 B | ||
|
Illumina
ILMN
|
163 | $ 192.79 | -3.92 % | $ 29.9 B | ||
|
Natera
NTRA
|
223 | $ 273.11 | -5.8 % | $ 37.3 B | ||
|
Koninklijke Philips N.V.
PHG
|
32 | $ 28.63 | -2.22 % | $ 27.1 B | ||
|
Fulgent Genetics
FLGT
|
17.1 | $ 24.03 | -3.03 % | $ 740 M | ||
|
CareDx, Inc
CDNA
|
18.6 | $ 69.9 | -2.81 % | $ 3.72 B | ||
|
Biomerica
BMRA
|
2.09 | $ 1.09 | -0.46 % | $ 3.18 M | ||
|
Interpace Biosciences
IDXG
|
1.66 | $ 4.4 | -4.35 % | $ 19.5 M | ||
|
Lantheus Holdings
LNTH
|
75.9 | $ 102.12 | 0.01 % | $ 6.89 B | ||
|
Senseonics Holdings
SENS
|
8.4 | $ 8.03 | -9.88 % | $ 335 M | ||
|
Sotera Health Company
SHC
|
16.7 | $ 15.92 | -1.82 % | $ 4.52 B | ||
|
ICON Public Limited Company
ICLR
|
129 | $ 186.79 | -1.88 % | $ 14.6 B | ||
|
Co-Diagnostics
CODX
|
4.4 | $ 0.13 | -22.11 % | $ 173 K | ||
|
Thermo Fisher Scientific
TMO
|
520 | $ 668.26 | -2.95 % | $ 252 B | ||
|
DarioHealth Corp.
DRIO
|
8.24 | $ 1.31 | -9.02 % | $ 5.22 M | ||
|
Myriad Genetics
MYGN
|
4.42 | $ 5.47 | -1.26 % | $ 507 M | ||
|
Precipio
PRPO
|
23.9 | $ 17.46 | -5.6 % | $ 28 M | ||
|
ENDRA Life Sciences
NDRA
|
5.6 | $ 3.58 | -3.38 % | $ 4.74 M | ||
|
QIAGEN N.V.
QGEN
|
38.3 | $ 49.28 | -0.72 % | $ 10.7 B | ||
|
NeoGenomics
NEO
|
11.6 | $ 14.8 | -1.95 % | $ 1.9 B | ||
|
OPKO Health
OPK
|
1.38 | $ 1.58 | -2.17 % | $ 1.19 B | ||
|
Pacific Biosciences of California
PACB
|
1.66 | $ 1.64 | -7.1 % | $ 492 M | ||
|
Neogen Corporation
NEOG
|
11.5 | $ 10.45 | -3.73 % | $ 2.27 B | ||
|
Personalis
PSNL
|
4.83 | $ 14.29 | -2.96 % | $ 1.28 B | ||
|
Quidel Corporation
QDEL
|
103 | $ 8.31 | -6.84 % | $ 350 M | ||
|
Centogene N.V.
CNTG
|
0.38 | - | -6.23 % | $ 30.6 M | ||
|
Waters Corporation
WAT
|
330 | $ 438.11 | -4.11 % | $ 26.1 B | ||
|
Neuronetics
STIM
|
1.23 | $ 1.24 | -4.44 % | $ 81.8 M | ||
|
Trinity Biotech plc
TRIB
|
0.54 | $ 6.24 | 13.76 % | $ 2.24 B |